Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-19 · accession 0001905871-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-23 | 2025-12-19+ | OLMA | Zojwalla Naseem | Chief Medical Off | S - Sale+OE | $27.94 | -269.5K | 4,488 | -98% | -$7.53M |
| DM | 2025-12-23 | 2025-12-19+ | OLMA | Zojwalla Naseem | Chief Medical Off | M - OptEx | $11.89 | +140.0K | 154.0K | +1,000% | +$1.66M |
| DM | 2025-12-23 | 2025-12-19+ | OLMA | Zojwalla Naseem | Chief Medical Off | M - OptEx | $0.00 | -140.0K | 112.2K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | S | D | 100,000 | $28.04 | 53,997 | D | — | — | (F4) The weighted average sale price for the transaction reported was $28.04, and the range of prices was between $27.655 and $28.36. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-12-19 | M | A | 40,000 | $15.25 | 173,997 | D | — | — | (F1) Includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. |
| 3 | Common | Common Stock | 2025-12-19 | S | D | 57,079 | $28.03 | 116,918 | D | — | — | (F2) The weighted average sale price for the transaction reported was $28.03, and the range of prices was between $27.50 and $28.49. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Common | Common Stock | 2025-12-19 | S | D | 12,921 | $28.93 | 103,997 | D | — | — | (F3) The weighted average sale price for the transaction reported was $28.93, and the range of prices was between $28.51 and $29.44. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Common | Common Stock | 2025-12-22 | M | A | 42,818 | $15.25 | 146,815 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-23 | S | D | 99,509 | $27.66 | 4,488 | D | — | — | (F5) The weighted average sale price for the transaction reported was $27.66, and the range of prices was between $27.50 and $27.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 7 | Common | Common Stock | 2025-12-23 | M | A | 50,000 | $7.02 | 103,997 | D | — | — | |
| 8 | Common | Common Stock | 2025-12-22 | M | A | 7,182 | $7.02 | 153,997 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-12-19 | M | D | 40,000 | $0.00 | 155,000 | D | $15.25 · — to 2034-01-31 | 40,000 Common Stock | (F6) 25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-12-23 | M | D | 50,000 | $0.00 | 156,818 | D | $7.02 · — to 2032-01-31 | 50,000 Common Stock | (F7) 25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |
| 11 | Derivative | Stock Option (Right to Buy) | 2025-12-22 | M | D | 7,182 | $0.00 | 206,818 | D | $7.02 · — to 2032-01-31 | 7,182 Common Stock | (F7) 25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |
| 12 | Derivative | Stock Option (Right to Buy) | 2025-12-22 | M | D | 42,818 | $0.00 | 112,182 | D | $15.25 · — to 2034-01-31 | 42,818 Common Stock | (F6) 25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |